XIENCE PRIME Everolimus Eluting Coronary Stent System (EECSS) China Single-Arm Study (XP China SAS)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01894152
Recruitment Status : Active, not recruiting
First Posted : July 10, 2013
Last Update Posted : August 15, 2016
Information provided by (Responsible Party):
Abbott Vascular

Results Submitted - Not Posted on
Results information has been submitted to by the sponsor or investigator, but is not yet publicly available (or "posted") on The submitted information may not be available if it is pending Quality Control (QC) Review by the National Library of Medicine (NLM) or if issues identified during QC review are being addressed or corrected by the sponsor or investigator. NLM's limited QC review assesses for apparent errors, deficiencies, or inconsistencies. NLM staff do not verify the scientific validity or relevance of the submitted information.
  Recruitment Status : Active, not recruiting
  Estimated Primary Completion Date : September 2019
  Estimated Study Completion Date : September 2019

Submission Cycle Results Submitted to Results Returned after Quality Control Review
1 August 16, 2017
September 13, 2017
2 April 9, 2018